Warrant Coverage Contract Clauses (99)

Grouped Into 3 Collections of Similar Clauses From Business Contracts

This page contains Warrant Coverage clauses in business contracts and legal agreements. We have organized these clauses into groups of similarly worded clauses.
Warrant Coverage. The Company shall issue to Wainwright or its designees at each Closing, warrants (the "Wainwright Warrants") to purchase that number of shares of common stock of the Company equal to 6.0% of the aggregate number of shares of common stock placed in each Offering (and if an Offering includes a "greenshoe" or "additional investment" option component, such number of shares of common stock underlying such additional option component, with the Wainwright Warrants issuable upon the exercise of such opt...ion). If the Securities included in an Offering are 430 Park Avenue | New York, New York 10022 | 212.356.0500 | www.hcwco.com Member: FINRA/SIPC convertible, the Wainwright Warrants shall be determined by dividing the gross proceeds raised in such Offering divided by the Offering Price (as defined hereunder). The Wainwright Warrants shall have the same terms as the warrants issued to investors in the applicable Offering, except that such Wainwright Warrants shall have an exercise price equal to 125% of the offering price per share (or unit, if applicable) in the applicable Offering and if such offering price is not available, the market price of the common stock on the date an Offering is commenced (such price, the "Offering Price"). If no warrants are issued to investors in an Offering, the Wainwright Warrants shall be in a customary form reasonably acceptable to Wainwright, have a term of five (5) years and an exercise price equal to 125% of the Offering Price. View More
Found in Axsome Therapeutics, Inc. contract
View All 29 Similar Clauses
Warrant Coverage. The Company shall issue to Wainwright or its designees at each Closing, warrants (the "Wainwright Warrants") to purchase that number of shares of common stock of the Company equal to 6.0% 5.0% of the aggregate number of shares of common stock placed (or common stock equivalent, if applicable) purchased in each Offering (and if an Offering includes a "greenshoe" or "additional investment" option component, such number of shares of common stock underlying such additional option component, with the... Wainwright Warrants issuable upon the closing of the exercise of such option). If the Securities included in an Offering are 430 Park Avenue | New York, New York 10022 | 212.356.0500 | www.hcwco.com Member: FINRA/SIPC convertible, the number of shares of common stock underlying the Wainwright Warrants shall be determined by dividing the gross proceeds raised in such Offering from the sale of shares of common stock (or common stock equivalent, if applicable) divided by the Offering Price (as defined hereunder). The Wainwright Warrants shall have the same terms as the warrants warrants, if any, issued to investors in the applicable Offering, except that such Wainwright Warrants shall have an exercise price equal to 125% of the offering price per share (or unit, if applicable) in the applicable Offering and if such offering price is not available, the market price of the common stock on the date an Offering is commenced (such price, the "Offering Price"). If no warrants are issued to investors in an Offering, the Wainwright Warrants shall be in a customary form (including, without limitation, with respect to anti-dilution rights) reasonably acceptable to Wainwright, have a term of five (5) years and an exercise price equal to 125% of the Offering Price. 430 Park Avenue | New York, New York 10022 | 212.356.0500 | www.hcwco.com Member: FINRA/SIPC 3. Expense Allowance. The Company also agrees to pay Wainwright, (a) out of the proceeds of each Closing, a management fee equal to 1.0% of the gross proceeds raised in such Offering, and (b) out of the proceeds of the first Closing, (i) the additional reimbursable amount payable by the Company pursuant to Paragraph D.3 hereunder, (ii) $25,000 for non-accountable expenses and (iii) up to $100,000 for reasonable and documented fees and expenses of legal counsel and other reasonable and documented out-of-pocket expenses; provided, that such reimbursement amount in no way limits or impairs the indemnification and contribution provisions of this Agreement. View More
Found in Diffusion Pharmaceuticals Inc. contract
Warrant Coverage. The Company shall issue to Wainwright or its designees at each Closing, warrants (the "Wainwright Warrants") to purchase that number of shares of common stock of the Company equal to 6.0% 5.0% of the aggregate number of shares of common stock placed in each Offering (and if an Offering includes a "greenshoe" or "additional investment" option component, such number of shares of common stock underlying such additional option component, with the Wainwright Warrants issuable upon the exercise of suc...h option). If the Securities included in an Offering are 430 Park Avenue | New York, New York 10022 | 212.356.0500 | www.hcwco.com Member: FINRA/SIPC convertible, the Wainwright Warrants shall be determined by dividing the gross proceeds raised in such Offering divided by the Offering Price (as defined hereunder). The Wainwright Warrants shall have the same terms as the warrants issued to investors in the applicable Offering, except that such Wainwright Warrants shall have an exercise price equal to 125% of the offering price per share (or unit, if applicable) in the applicable Offering and if such offering price is not available, the market price of the common stock on the date an Offering is commenced (such price, the "Offering Price"). If no warrants are issued to investors in an Offering, the Wainwright Warrants shall be in a customary form reasonably acceptable to Wainwright, have Wainwright and the Company, be exercisable from the 6-month anniversary of the issuance date for a term of five (5) three and one-half (3.5) years and at an exercise price equal to 125% of the Offering Price. Price, shall not have any price-based anti-dilution protection, and neither the Wainwright Warrants or the shares underlying them shall be subject to registration except in the sole discretion of the Company. View More
Found in Microbot Medical Inc. contract
Warrant Coverage. The Company shall issue to Wainwright or its designees at each the Closing, warrants (the "Wainwright Warrants") to purchase that number of shares of common stock of the Company equal to 6.0% 7.0% of the aggregate number of shares of common stock (or common stock equivalent, if applicable) placed in each the Offering (and if an the Offering includes a "greenshoe" or "additional investment" option component, such number of shares of common stock underlying such additional option "greenshoe" or "a...dditional investment" component, with the Wainwright Warrants issuable upon the exercise of such option). component). If the Securities included in an the Offering are 430 Park Avenue | New York, New York 10022 | 212.356.0500 | www.hcwco.com Member: FINRA/SIPC convertible, the Wainwright Warrants shall be determined by dividing the gross proceeds raised in such the Offering divided by the Offering Price (as defined hereunder). The Wainwright Warrants shall be in a customary form reasonably acceptable to Wainwright, have a term of five (5) years and an exercise price equal to 125% of the offering price per share (or unit, if applicable) in the Offering and if such offering price is not available, the market price of the common stock on the date the Offering is commenced (such price, the "Offering Price"). If warrants are issued to investors in an Offering, the Wainwright Warrants shall have the same terms as the warrants issued to investors in the applicable Offering, except that such Wainwright Warrants shall have an exercise price equal to 125% of the offering price per share (or unit, if applicable) in the applicable Offering and if such offering price is not available, the market price of the common stock on the date an Offering is commenced (such price, the "Offering Price"). If no warrants are issued to investors in an Offering, the Wainwright Warrants shall be in a customary form reasonably acceptable to Wainwright, have a term of five (5) years and an exercise price equal to 125% of the Offering Price. View More
Found in Outlook Therapeutics, Inc. contract
View Variations (29)
Warrant Coverage. The Company shall issue to Rodman or its designees at each Closing, warrants (the "Rodman Warrants") to purchase that number of shares of common stock of the Company equal to 7% of the aggregate number of shares of Common Stock placed in each Offering (if the Securities are convertible or include a "greenshoe" or "additional investment" option component, such shares of Common Stock underlying such Securities or options shall not be included). If the 430 Park Avenue | New York, New York 10022 | 2...12.356.0500 Security services provided by H.C. Wainwright & Co., LLC | Member: FINRA/SIPC Securities included in an Offering are non-convertible, the Rodman Warrants shall be determined by dividing the gross proceeds raised in such Offering divided by the then market price of the Common Stock. The Rodman Warrants shall have the same terms as the warrants issued to investors in the applicable Offering, except that the Rodman Warrants shall have a term of five years, and an exercise price equal to 125% of the per share offering price and shall not have any provisions requiring registration of the underlying shares. If no warrants are issued to investors in an Offering, the Rodman Warrants shall be in a customary form reasonably acceptable to Rodman and the Company, have a term of 5 years and an exercise price equal to 125% of the then market price of the Common Stock. View More
Found in GENVEC INC contract
View All 11 Similar Clauses
Warrant Coverage. The Company shall issue to Rodman or its designees at each Closing, warrants (the "Rodman Warrants") to purchase that number of shares of common stock of the Company equal to 7% 5% of the aggregate number of shares of Common Stock placed in each the Offering (if the Securities are convertible or include a "greenshoe" or "additional investment" option component, such shares of Common Stock underlying such Securities or options shall not be included). options). If the 430 Park Avenue | New York, N...ew York 10022 | 212.356.0500 Security services provided by H.C. Wainwright & Co., LLC | Member: FINRA/SIPC Securities included in an Offering are non-convertible, the Rodman Warrants shall be determined by dividing the gross proceeds raised in such Offering divided by the then market price of the Common Stock. The Rodman Warrants shall have the same terms as the warrants issued to investors in the applicable Offering, except that the Rodman Warrants shall have a term of five years, and an exercise price equal to 125% of the per share offering price and shall not have any provisions requiring registration of the underlying shares. Offering. If no warrants are issued to investors in an Offering, the Rodman Warrants shall be in a customary form reasonably acceptable to Rodman and the Company, Rodman, have a term of 5 years and an exercise price equal to 125% 110% of the then market price of the Common Stock. View More
Found in Biostage, Inc. contract
Warrant Coverage. The Company shall issue to Rodman or its designees at each Closing, warrants (the "Rodman Warrants") to purchase that number of shares of common stock of the Company equal to 7% 5.0% of the aggregate number of shares of Common Stock placed in each Offering (if the Securities are convertible or include a "greenshoe" or "additional investment" option component, such shares of Common Stock underlying such Securities or options shall not be included). options). If the 430 Park Avenue | New York, New... York 10022 | 212.356.0500 Security services provided by H.C. Wainwright & Co., LLC | Member: FINRA/SIPC Securities included in an Offering are non-convertible, the Rodman Warrants shall be determined by dividing the gross proceeds raised in such Offering divided by the then market price of the Common Stock. The Rodman Warrants shall have the same terms as the warrants issued to investors in the applicable Offering, except that the Rodman Warrants shall have a term of five years, no greater than 5 years and an exercise price equal to 125% of the per share public offering price and shall not have any provisions requiring registration of the underlying shares. an Offering. If no warrants are issued to investors in an Offering, the Rodman Warrants shall be in a customary form reasonably acceptable to Rodman and the Company, Rodman, have a term of 5 years and an exercise price equal to 125% of the then market price of the Common Stock. 430 Park Avenue | New York, New York 10022 | 212.356.0500 Security services provided by H.C. Wainwright & Co., LLC | Member: FINRA/SIPC 3. Expense Allowance. Out of the proceeds of each Closing, the Company also agrees to pay Rodman $50,000 for expenses of Rodman, including legal fees and expenses in connection with marketing the transaction (i.e., road show expenses, background checks, tombstones, etc.) (provided, however, that such reimbursement amount in no way limits or impairs the indemnification and contribution provisions of this Agreement). View More
Found in APRICUS BIOSCIENCES, INC. contract
Warrant Coverage. The Company shall issue to Rodman or its designees at each Closing, warrants (the "Rodman Warrants") to purchase that number of shares of common stock of the Company equal to 7% 5% of the aggregate number of shares of Common Stock placed in each Offering (if (and if the Securities are convertible or include a "greenshoe" or "additional investment" option component, such number of shares of Common Stock underlying such Securities or options shall not be included). options, with the warrant issuab...le upon conversion of the Securities or the exercise of the option). If the 430 Park Avenue | New York, New York 10022 | 212.356.0500 Security services provided by H.C. Wainwright & Co., LLC | Member: FINRA/SIPC Securities included in an Offering are non-convertible, the Rodman Warrants shall be determined by dividing the gross proceeds raised in such Offering divided by the then market price of the Common Stock. The Rodman Warrants shall have the same terms as the warrants issued to investors in the applicable Offering, except that the such Rodman Warrants Warrant shall have a term of five years, and an exercise price equal to 125% of the public offering price per share offering price and shall not have any provisions requiring registration of in the underlying shares. applicable Offering. If no warrants are issued to investors in an Offering, the Rodman Warrants shall be in a customary form reasonably acceptable to Rodman and the Company, Rodman, have a term of 5 years and an exercise price equal to 125% of the then market price of the Common Stock. View More
Found in CEL SCI CORP contract
View Variations (11)
Warrant Coverage. Upon receipt of the loan amount in the accounts of the Company, the Company shall issue a warrant to the Holder to purchase 1,000,000 restricted shares of Common Stock in the form attached hereto as Exhibit B.
Found in PARETEUM Corp contract
Warrant Coverage. Upon receipt of the loan amount in the accounts of the Company, the Company shall issue a warrant to the Holder to purchase 1,000,000 2,000,000 restricted shares of Common Stock in the form attached hereto as Exhibit B.
Found in PARETEUM Corp contract
View Variation